Research published in The Journal of Clinical Psychiatry characterizes patient-reported improvement with INGREZZA® (valbenazine) capsules across the KINECT® clinical ...

Taylor Thomas Harris uses her social media platform to share her journey with Cerebral Palsy and Functional Neurological ...

Neurocrine Biosciences, Inc.  today announced the publication of new peer-reviewed research in The Journal of Clinical Psychiatry demonstrating how the Tardive Dyskinesia Impact Scale helps ...

The decision, released by Ontario's Licence Appeal Tribunal on April 17, 2026, is a pointed reminder to claims professionals ...

Among more than 2,000 patients who completed a TDScreen assessment, 156 received a Tardive Dyskinesia diagnosis and 125 were prescribed treatment, real-world evidence that AI-enabled screening is clos ...

Awareness Week (May 3-9, 2026) brings attention to TD and aims to reduce stigma and support those affected by the condition. This important week unites ...

The health secretary has previously shared how spasmodic dysphonia, a neurological voice disorder, impacts his speech and ...

Marietta, chair of the House Public and Community Health Committee, announced that the first full week of May will be ...

Saliers made the announcement ahead of the duo's upcoming tour Indigo Girls/Instagram Emily Saliers of Indigo Girls announced she has been diagnosed with cervical dystonia and an essential tremor in ...

Neurocrine Biosciences, Inc.  today announced the presentation of new real-world evidence demonstrating that adult patients with tardive dyskinesia receiving INGREZZA® (valbenazine) capsules showed ...

(WHTM) — Penn State Health will now offer a new treatment for movement disorders such as Parkinson’s disease and essential tremor. Focused ultrasound, an FDA-approved treatment, uses sound waves ...

Press releases are posted on Independent.com as a free community service. SANTA BARBARA, Calif. (March 17, 2026) A study by an international team of researchers led by Santa Barbara City College (SBCC ...